← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.

Crismita Dmello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 35552677